| |
| |
|
| Insider
Information: |
Blight Andrew |
| Relationship: |
Chief Scientific Officer |
| City: |
Hawthorne |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
76,558 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$38,432 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
76,558 |
|
|
| Total
Value |
$38,432 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Acorda Therapeutics Inc |
ACOR |
Chief Scientific Officer |
2017-02-09 |
76,558 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ACOR |
Acorda Therapeutics Inc |
Chief Scientific Officer |
• – – |
2017-02-09 |
4 |
AS |
$22.41 |
$1,514,379 |
D/D |
(67,586) |
76,558 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Scientific Officer |
• – – |
2017-02-09 |
4 |
OE |
$22.13 |
$1,495,678 |
D/D |
67,586 |
144,144 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Scientific Officer |
• – – |
2016-12-01 |
4 |
AS |
$20.76 |
$100,774 |
D/D |
(4,855) |
76,558 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Scientific Officer |
• – – |
2016-08-09 |
4 |
OE |
$22.13 |
$215,856 |
D/D |
9,754 |
81,413 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Scientific Officer |
• – – |
2015-11-20 |
4 |
OE |
$8.50 |
$4,250 |
D/D |
500 |
72,159 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Scientific Officer |
• – – |
2015-11-20 |
4 |
AS |
$37.47 |
$18,735 |
D/D |
(500) |
71,659 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Scientifc Officer |
• – – |
2015-10-19 |
4 |
AS |
$30.82 |
$1,003,117 |
D/D |
(32,500) |
71,659 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Scientifc Officer |
• – – |
2015-10-19 |
4 |
OE |
$5.85 |
$190,125 |
D/D |
32,500 |
104,159 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Scientifc Officer |
• – – |
2015-09-21 |
4 |
AS |
$30.85 |
$409,612 |
D/D |
(13,085) |
71,659 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Scientifc Officer |
• – – |
2015-09-21 |
4 |
OE |
$6.00 |
$78,510 |
D/D |
13,085 |
84,744 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Scientifc Officer |
• – – |
2015-03-04 |
4 |
A |
$0.00 |
$0 |
D/D |
5,872 |
71,659 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Scientifc Officer |
• – – |
2014-10-20 |
4 |
AS |
$32.08 |
$1,678,788 |
D/D |
(52,338) |
65,787 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Scientifc Officer |
• – – |
2014-10-20 |
4 |
OE |
$8.14 |
$426,031 |
D/D |
52,338 |
118,125 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Scientifc Officer |
• – – |
2014-03-05 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
65,787 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Scientifc Officer |
• – – |
2013-12-02 |
4 |
AS |
$33.51 |
$304,563 |
D/D |
(9,088) |
59,787 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Scientifc Officer |
• – – |
2013-07-19 |
4 |
AS |
$37.82 |
$729,775 |
D/D |
(19,296) |
68,875 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Scientifc Officer |
• – – |
2013-07-19 |
4 |
OE |
$2.60 |
$50,170 |
D/D |
19,296 |
88,171 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Scientifc Officer |
• – – |
2013-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
7,550 |
68,875 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Scientifc Officer |
• – – |
2012-12-03 |
4 |
AS |
$24.20 |
$174,244 |
D/D |
(7,200) |
61,325 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Scientifc Officer |
• – – |
2012-10-22 |
4 |
OE |
$2.60 |
$24,651 |
D/D |
9,481 |
78,006 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Scientifc Officer |
• – – |
2012-10-22 |
4 |
AS |
$23.08 |
$218,821 |
D/D |
(9,481) |
68,525 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Scientifc Officer |
• – – |
2012-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
13,800 |
68,525 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Scientifc Officer |
• – – |
2011-12-01 |
4 |
AS |
$22.92 |
$160,440 |
D/D |
(7,000) |
54,725 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Scientifc Officer |
• – – |
2011-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
61,725 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Scientifc Officer |
• – – |
2010-12-01 |
4 |
D |
$26.47 |
$142,488 |
D/D |
(5,383) |
46,725 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
